Multimodal prehabilitation significantly reduces postoperative complications in esophago-gastric cancer surgery, highlighting its importance in surgical care. Respiratory complications fell from 43.8% to 20.9% with prehabilitation (p=0.010). Cardiac issues decreased from 22.3% to 7.0% (p=0.037), and hepatic and renal complications were eliminated in the prehabilitation cohort. Integrating prehabilitation can improve patient selection and optimize outcomes. Hospital […]

Higher lymph node yield after neoadjuvant chemoimmunotherapy improves disease-free survival in esophageal squamous cell carcinoma, guiding surgical practices. Patients with no residual disease (ypt0-2n0) saw improved survival with 20-30 lymph nodes; benefits plateau beyond this range. In cases with residual disease (ypn1-3), higher yields correlated with longer disease-free survival. Improving lymph node dissection may serve […]

Laparoscopic-assisted total gastrectomy for resectable gastric cancer yields favorable long-term survival rates. Five-year overall survival is 62.5%, with a recurrence-free survival rate of 60.3%. Recurrence occurs in 40% of patients, primarily as distant metastases (61.4%). Understanding early and late recurrence, with a critical 12-month cutoff, can refine postoperative follow-up. An early recurrence prediction model outperforms […]

Surgeons should scrutinize YouTube content on esophageal cancer as video reliability is inconsistent, impacting patient education. Out of 78 analyzed videos, those from public institutions had the highest quality scores, significantly better than patient experience videos (p < 0.001). Viewer engagement levels showed no correlation with video quality; popularity doesn’t guarantee reliable information. Surgeons might […]

In a study of 2,388 patients, those with BMI ≥35 had similar symptom improvement (GERD-HRQL scores: 10.7 vs. 10.1) and satisfaction rates (81.6% vs. 83.3%) post-operation compared to non-obese patients. Five-year anatomic integrity (75.8% vs. 78.2%) and revision rates (4.5% vs. 5.3%) were also comparable. However, obese patients had lower rates of pH normalization in […]

Robotic multivisceral resection is feasible and beneficial for select patients with locally advanced gastroesophageal junction tumors. A 6.3-cm T4BN2 adenocarcinoma was successfully resected within 6 hours post-neoadjuvant FOLFOX chemotherapy. The approach allowed for R0 resection while maintaining quality of life through careful patient selection and technique. Surgical teams should consider this method for eligible patients […]

Proximal gastrectomy offers survival rates similar to total gastrectomy after neoadjuvant therapy for Siewert Type II/III gastric adenocarcinoma. No significant differences in overall survival (p = 0.54) or progression-free survival (p = 0.86) were found between the two approaches. The study included a balanced cohort of 518 patients from three centers, reinforcing the findings across […]